Oligonol's Dermatological Benefits Presented at the "New Trends on Longevity Medicine & Aesthetic Procedures" Conference

On December 1, 2007, Oligonol was presented as an extremely effective means of protection from solar radiation exposure. 

At the “New Trends on Longevity Medicine & Aesthetic Procedures” conference in Geneva, Switzerland, Dr. Albert R. Mackenzie offered his argument for Oligonol. Mackenzie discussed Oligonol, calling it “one of the most promising new anti-oxidant interventions for topical use”, highlighting its attractive and distinctive feature: short chain polyphenols, “When a long chain polyphenol is broken down into its short chains, it has more anti-oxidant sites available” said Mackenzie. Dr. Mackenzie than provided the polyphenol composition of Oligonol by means of a color bar chart, and discussed the bioactivity of Oligonol. The presentation was concluded by addressing the amount of sunscreen and proper dress in order to be effectively protected from solar radiation. Mackenzie also mentioned inducing changes in the expression of inflammation and age-related genes.

The conference was funded by the Swiss Academy of Anti-Aging Medicine and took place November 29-December 1, 2007 at the Ramada Park Hotel in Geneva, Switzerland. Attending were physicians and medical practitioners from at least fifteen countries.

In June 2007 the Maypro Group announced acceptance from the Food and Drug Administration (FDA) for their patented ingredient, Oligonol. The FDA concluded Oligonol to be safe and usable in the United States market. Oligonol is an all-natural ingredient, heavy in anti-oxidants. The ingredient is made up of oligomerized polyphenols that promote healthy aging as well as skin improvement. Polyphenols are typically found in plants and are known for their antioxidant, anti-aging abilities. Oligonol is manufactured from lychee fruit using a process that shortens polyphenol polymers into lychee fruit monomers and short chain oligomers, making them more bioavailable in the body.

Albert R MacKenzie is a graduate of the University of Michigan at Ann Arbor. It was at the University of Michigan Medical School and Medical Center he received his medical training and completed his internship and residency in the field of Dermatology. It was also at the University of Michigan Medical Center School of Public Health he completed a one year fellowship in Epidemiology as well as a medical externship in Mycology Research, through the department of dermatology. Dr. MacKenzie had taught numerous, annual courses at the American Academy of Dermatology and is a founding member of both the American Societic of Dermatologic Surgery and the International Society of Dermatologic Surgery (ISDS). In addition to various publications of articles and journals, MacKenzie is a board certified Diplomate of the American Board of Dermatology, with his own private practice in Encino, California.

Founded in 1977, Maypro Group is a privately held, global provider of raw materials for nutritional supplements, sports nutrition, pet & veterinary, cosmetic, functional food and fine chemical industries. With a headquarters in Purchase, New York and offices in major cities such as, Los Angeles, Tokyo and Shanghai, Maypro represents some of the world’s largest nutraceutical ingredient manufacturers, and supplies high-quality ingredients in the U.S., Japan, Europe, Latin America and throughout Asia. Maypro has established itself as an industry leader, being the first to introduce leading ingredients such as Coenzyme Q10, AHCC medicinal mushrooms, chondroitin, glucosamine, and alpha-lipoic acid to the United States market. Maypro has also launched these leading U.S. and European patented, branded ingredients in Japan. For more information visit, www.maypro.com